Logo-npj

J Nephropharmacol. 2024;13(2): e12688. doi: 10.34172/npj.2024.12688

Meta Analysis

The association between the utilization of SGLT2 inhibitors and diabetic retinopathy; a systematic review and meta-analysis of cohort studies

Shahriar Barkhordari 1 ORCID, Shahrzad Ghaffariyan 2,3 ORCID, Farzin Banei 4 ORCID, Mohammad Shirvani 5 ORCID, Farangis yazdanjou 1 ORCID, Sara Ghaseminejad Kermani 6 ORCID, Mohammad Akbari 7 ORCID, Alireza Baghaei 8 ORCID, Mobin Mohammadtabar 9 * ORCID

Cited by CrossRef: 0

1- Lin L, Wu J, Jeng W, Tsai C, Sun J, Kuo C, Yuliani F, Lin S. Ocular Complications of SGLT‐2 Inhibitors, GLP‐1 Receptor Agonists, and DPP‐4 Inhibitors in T2DM Treatments: A Retrospective Real‐World Cohort Study. Clin Pharma and Therapeutics. 2026;119(1):255 [Crossref]
2- Ortiz-Seller A, Ortiz-Seller D, Morcillo E, Ortiz J. Sodium-glucose cotransporter-2 inhibitors and risk of diabetic retinopathy in type 2 diabetes: a network meta-analysis of randomised clinical trials. Int J Clin Pharm. 2025; [Crossref]